Literature DB >> 28581198

FBXW7 inactivation in a BrafV600E -driven mouse model leads to melanoma development.

Iraz T Aydin1,2,3, Franco Abbate1,2,3, Geena Susan Rajan1,2,3, Brateil Badal1,2,3, Iannis Aifantis4, Garrett Desman1, Julide Tok Celebi1,2,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28581198      PMCID： PMC5668175          DOI： 10.1111/pcmr.12603

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  10 in total

Review 1.  Oncogene-induced senescence and melanoma: where do we stand?

Authors:  Daniel S Peeper
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

Review 2.  Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.

Authors:  Ryan J Davis; Markus Welcker; Bruce E Clurman
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

Review 3.  Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.

Authors:  Nikos Kourtis; Alexandros Strikoudis; Iannis Aifantis
Journal:  Curr Opin Cell Biol       Date:  2015-09-28       Impact factor: 8.382

4.  Genomic Classification of Cutaneous Melanoma.

Authors: 
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

5.  Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Authors:  Liesbeth C W Vredeveld; Patricia A Possik; Marjon A Smit; Katrin Meissl; Chrysiis Michaloglou; Hugo M Horlings; Abderrahim Ajouaou; Pim C Kortman; David Dankort; Martin McMahon; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

6.  BRAFE600-associated senescence-like cell cycle arrest of human naevi.

Authors:  Chrysiis Michaloglou; Liesbeth C W Vredeveld; Maria S Soengas; Christophe Denoyelle; Thomas Kuilman; Chantal M A M van der Horst; Donné M Majoor; Jerry W Shay; Wolter J Mooi; Daniel S Peeper
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

7.  Elucidating distinct roles for NF1 in melanomagenesis.

Authors:  Ophélia Maertens; Bryan Johnson; Pablo Hollstein; Dennie T Frederick; Zachary A Cooper; Ludwine Messiaen; Roderick T Bronson; Martin McMahon; Scott Granter; Keith Flaherty; Jennifer A Wargo; Richard Marais; Karen Cichowski
Journal:  Cancer Discov       Date:  2012-11-21       Impact factor: 39.397

8.  The Genetic Evolution of Melanoma from Precursor Lesions.

Authors:  A Hunter Shain; Iwei Yeh; Ivanka Kovalyshyn; Aravindhan Sriharan; Eric Talevich; Alexander Gagnon; Reinhard Dummer; Jeffrey North; Laura Pincus; Beth Ruben; William Rickaby; Corrado D'Arrigo; Alistair Robson; Boris C Bastian
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

9.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

10.  Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.

Authors:  Amaya Viros; Berta Sanchez-Laorden; Malin Pedersen; Simon J Furney; Joel Rae; Kate Hogan; Sarah Ejiama; Maria Romina Girotti; Martin Cook; Nathalie Dhomen; Richard Marais
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962
  10 in total
  4 in total

1.  FBXW7 regulates a mitochondrial transcription program by modulating MITF.

Authors:  Franco Abbate; Brateil Badal; Karen Mendelson; Iraz T Aydin; Madhavika N Serasinghe; Ramiz Iqbal; Jarvier N Mohammed; Alexander Solovyov; Benjamin D Greenbaum; Jerry E Chipuk; Julide T Celebi
Journal:  Pigment Cell Melanoma Res       Date:  2018-04-29       Impact factor: 4.693

Review 2.  Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Med Sci (Basel)       Date:  2017-11-20

3.  Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.

Authors:  Juan He; Zhen Zeng; Yuelong Wang; Jiaojiao Deng; Xin Tang; Fujun Liu; Jianhan Huang; Hongxu Chen; Ruichao Liang; Xin Zan; Zhiyong Liu; Aiping Tong; Gang Guo; Jianguo Xu; Xiaofeng Zhu; Liangxue Zhou; Yong Peng
Journal:  Mol Cancer       Date:  2021-12-18       Impact factor: 27.401

Review 4.  Clinical significance of FBXW7 loss of function in human cancers.

Authors:  Jingyi Fan; Marcia Bellon; Mingyi Ju; Lin Zhao; Minjie Wei; Liwu Fu; Christophe Nicot
Journal:  Mol Cancer       Date:  2022-03-26       Impact factor: 27.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.